Branched-chain amino acids and ammonia metabolism in liver disease: Therapeutic implications

Nutrition

Volumn 29, Issue 10, 2013, Pages 1186-1191

  Holecek, Milan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Alpha ketoglutarate; Glutamine; Liver cirrhosis; Nutrition; Phenylbutyrate

Indexed keywords

2 OXOGLUTARIC ACID; AMMONIA; AROMATIC AMINO ACID; ARYLBUTYRIC ACID DERIVATIVE; BRANCHED CHAIN AMINO ACID; DOPAMINE; GLUTAMINE; ISOLEUCINE; LEUCINE; NORADRENALIN; PHENYLALANINE; SEROTONIN; TRYPTOPHAN; TYROSINE; VALINE;

AMINO ACID BLOOD LEVEL; AMINO ACID DEFICIENCY; AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; AMINO ACID URINE LEVEL; AMMONIA FORMATION; BRANCHED CHAIN AMINO ACID DEFICIENCY; DETOXIFICATION; DIET SUPPLEMENTATION; DOPAMINE METABOLISM; DOSE RESPONSE; ELIMINATION REACTION; GASTROINTESTINAL HEMORRHAGE; GLUCOSE METABOLISM; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; HYPERGLUTAMINEMIA; INFLAMMATION; INTESTINE CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; NONHUMAN; NUTRITIONAL DEFICIENCY; OUTCOME ASSESSMENT; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW; SKELETAL MUSCLE; UREA CYCLE DISORDER; URINARY EXCRETION;

ALPHA-KETOGLUTARATE; GLUTAMINE; LIVER CIRRHOSIS; NUTRITION; PHENYLBUTYRATE;

AMINO ACIDS, BRANCHED-CHAIN; AMMONIA; ANIMALS; DISEASE MODELS, ANIMAL; GLUTAMINE; HEPATIC ENCEPHALOPATHY; HUMANS; KETOGLUTARIC ACIDS; KIDNEY; LIVER CIRRHOSIS; MUSCLE, SKELETAL; PHENYLBUTYRATES;

EID: 84884203912     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.01.022     Document Type: Review

References (74)

1. Freund H., Hoover H.C., Atamian S., Fischer J.E. Infusion of the branched chain amino acids in postoperative patients. Anticatabolic properties. Ann Surg 1979, 190:18-23.
2. Fischer J.E. Branched-chain-enriched amino acid solutions in patients with liver failure: an early example of nutritional pharmacology. JPEN J Parenter Enteral Nutr 1990, 14:249S-256S.
3. Rössle M., Luft M., Herz R., Klein B., Lehmann M., Gerok W. Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution. Klin Wochenschr 1984, 62:867-875.
4. Rossi Fanelli F., Cangiano C., Capocaccia L., Cascino A., Ceci F., Muscaritoli M., et al. Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences. Gut 1986, 27:111-115.
5. Plauth M., Egberts E.H., Hamster W., Török M., Müller P.H., Brand O., et al. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study. JHepatol 1993, 17:308-314.
6. Watanabe A., Shiota T., Okita M., Nagashima H. Effect of a branched chain amino acid-enriched nutritional product on the pathophysiology of the liver and nutritional state of patients with liver cirrhosis. Acta Med Okayama 1983, 37:321-333.
7. Holecek M., Simek J., Kruf M., Zadak Z. Effect of branched-chain amino acids on liver regeneration after partial hepatectomy. Physiol Bohemoslov 1985, 34:359-366.
8. Rigotti P., Peters J.C., Tranberg K.O., Fischer J.E. Effect of amino acid infusion on liver regeneration after partial hepatectomy in the rat. JPEN J Parenter Enteral Nutr 1986, 10:17-20.
9. Holecek M., Simek J., Palicka V., Zadak Z. Effect of glucose and branched chain amino acids (BCAA) infusion on onset of liver regeneration and plasma amino acid pattern in partially hepatectomized rat. J Hepatol 1991, 13:14-20.
10. Alexander W.F., Spindel E., Harty R.F., Cerda J.J. The usefulness of branched chain amino acids in patients with acute or chronic hepatic encephalopathy. Am J Gastroenterol 1989, 84:91-96.
11. Wahren J., Denis J., Desurmont P., Eriksson L.S., Escoffier J.M., Gauthier A.P., et al. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology 1983, 3:475-480.
12. Kanematsu T., Koyanagi N., Matsumata T., Kitano S., Takenaka K., Sugimachi K. Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial. Surgery 1988, 104:482-488.
13. Marchesini G., Bianchi G., Merli M., Amodio P., Panella C., Loguercio C., et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 2003, 124:1792-1801.
14. Muto Y., Sato S., Watanabe A., Moriwaki H., Suzuki K., Kato A., et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005, 3:705-713.
15. Fukushima H., Miwa Y., Shiraki M., Gomi I., Toda K., Kuriyama S., et al. Oral branched-chain amino acid supplementation improves the oxidized/reduced albumin ratio in patients with liver cirrhosis. Hepatol Res 2007, 37:765-770.
16. Kawaguchi T., Nagao Y., Matsuoka H., Ide T., Sata M. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease. Int J Mol Med 2008, 22:105-112.
17. Kawamura E., Habu D., Morikawa H., Enomoto M., Kawabe J., Tamori A., et al. A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status. Liver Transpl 2009, 15:790-797.
18. Holecek M. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition 2010, 26:482-490.
19. Kim S.J., Kim D.G., Lee M.D. Effects of branched-chain amino acid infusions on liver regeneration and plasma amino acid patterns in partially hepatectomized rats. Hepatogastroenterology 2011, 58:1280-1285.
20. Nakaya Y., Okita K., Suzuki K., Moriwaki H., Kato A., Miwa Y., et al. Hepatic Nutritional Therapy (HNT) Study Group. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007, 23:113-120.
21. Plauth M., Schütz T. Branched-chain amino acids in liver disease: new aspects of long known phenomena. Curr Opin Clin Nutr Metab Care 2011, 14:61-66.
22. Plauth M., Cabré E., Riggio O., Assis-Camilo M., Pirlich M., Kondrup J., et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 2006, 25:285-294.
23. Les I., Doval E., García-Martínez R., Planas M., Cárdenas G., Gómez P., et al. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. Am J Gastroenterol 2011, 106:1081-1088.
24. Gluud LL, Dam G, Borre M, Les I, Cordoba J, Marchesini G, etal. Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence? Metab Brain Dis (in press).
25. Ruderman N.B., Berger M. The formation of glutamine and alanine in skeletal muscle. J Biol Chem 1974, 249:5500-5506.
26. Odessey R., Khairallah E.A., Goldberg A.L. Origin and possible significance of alanine production by skeletal muscle. J Biol Chem 1974, 249:7623-7629.
27. Dam G., Keiding S., Munk O.L., Ott P., Buhl M., Vilstrup H., et al. Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects. Am J Physiol 2011, 301:G269-G277.
28. Garlick P.J. The role of leucine in the regulation of protein metabolism. J Nutr 2005, 135:1553S-1556S.
29. Kawaguchi T., Izumi N., Charlton M.R., Sata M. Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology 2011, 54:1063-1070.
30. Nair K.S., Short K.R. Hormonal and signaling role of branched-chain amino acids. J Nutr 2005, 135:1547S-1552S.
31. Khanna S., Gopalan S. Role of branched-chain amino acids in liver disease: the evidence for and against. Curr Opin Clin Nutr Metab Care 2007, 10:297-303.
32. Tomiya T., Inoue Y., Yanase M., Arai M., Ikeda H., Tejima K., et al. Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells. Biochem Biophys Res Commun 2002, 297:1108-1111.
33. Nishimura J., Masaki T., Arakawa M., Seike M., Yoshimatsu H. Isoleucine prevents the accumulation of tissue triglycerides and upregulates the expression of PPARalpha and uncoupling protein in diet-induced obese mice. J Nutr 2010, 140:496-500.
34. Kakazu E., Ueno Y., Kondo Y., Fukushima K., Shiina M., Inoue J., et al. Branched chain amino acids enhance the maturation and function of myeloid dendritic cells exvivo in patients with advanced cirrhosis. Hepatology 2009, 50:1936-1945.
35. Nakamura I., Ochiai K., Imawari M. Phagocytic function of neutrophils of patients with decompensated liver cirrhosis is restored by oral supplementation of branched-chain amino acids. Hepatol Res 2004, 29:207-211.
36. Nakamura I., Ochiai K., Imai Y., Moriyasu F., Imawari M. Restoration of innate host defense responses by oral supplementation of branched-chain amino acids in decompensated cirrhotic patients. Hepatol Res 2007, 37:1062-1067.
37. Tischler M.E., Desautels M., Goldberg A.L. Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle?. J Biol Chem 1982, 257:1613-1621.
38. Holecek M., Muthny T., Kovarik M., Sispera L. Effect of beta-hydroxy-beta-methylbutyrate (HMB) on protein metabolism in whole body and in selected tissues. Food Chem Toxicol 2009, 47:255-259.
39. Kovarik M., Muthny T., Sispera L. Holecek M Effects of β-hydroxy-β-methylbutyrate treatment in different types of skeletal muscle of intact and septic rats. J Physiol Biochem 2010, 66:311-319.
40. Iber F.L., Rosen H., Levenson S.M., Chalmers T.C. The plasma amino acids in patients with liver failure. J Lab Clin Med 1957, 50:417-425.
41. Holecek M., Mraz J., Tilser I. Plasma amino acids in four models of experimental liver injury in rats. Amino Acids 1996, 10:229-241.
42. Leweling H., Breitkreutz R., Behne F., Staedt U., Striebel J.P., Holm E. Hyperammonemia-induced depletion of glutamate and branched-chain amino acids in muscle and plasma. J Hepatol 1996, 25:756-762.
43. Holecek M., Sprongl L., Tichy M. Effect of hyperammonemia on leucine and protein metabolism in rats. Metabolism 2000, 49:1330-1334.
44. Safranek R., Holecek M., Sispera L., Muthny T. Aspects of protein and amino acid metabolism in a model of severe glutamine deficiency in sepsis. Ann Nutr Metab 2006, 50:361-367.
45. Suryawan A., Hawes J.W., Harris R.A., Shimomura Y., Jenkins A.E., Hutson S.M. A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr 1998, 68:72-81.
46. Holecek M., Kandar R., Sispera L., Kovarik M. Acute hyperammonemia activates branched-chain amino acid catabolism and decreases their extracellular concentrations: different sensitivity of red and white muscle. Amino Acids 2011, 40:575-584.
47. Fischer J.E., Baldessarini R.J. False neurotransmitters and hepatic failure. Lancet 1971, ii:75-80.
48. James J.H., Ziparo V., Jeppsson B., Fischer J.E. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet 1979, 2:772-775.
49. Desjardins P., Du T., Jiang W., Peng L., Butterworth R.F. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined. Neurochem Int 2012, 60:690-696.
50. Freund H., Dienstag J., Lehrich J., Yoshimura N., Bradford R.R., Rosen H., et al. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy. Ann Surg 1982, 196:209-220.
51. MacLean D.A., Graham T.E. Branched-chain amino acid supplementation augments plasma ammonia responses during exercise in humans. J Appl Physiol 1993, 74:2711-2717.
52. Pencharz P.B., Elango R., Ball R.O. Determination of the tolerable upper intake level of leucine in adult men. J Nutr 2012, 142:2220S-2224S.
53. Holecek M., Tilser I., Skopec F., Sprongl L. Leucine metabolism in rats with cirrhosis. J Hepatol 1996, 24:209-216.
54. Kato M., Miwa Y., Tajika M., Hiraoka T., Muto Y., Moriwaki H. Preferential use of branched-chain amino acids as an energy substrate in patients with liver cirrhosis. Intern Med 1998, 37:429-434.
55. Shimomura Y., Honda T., Shiraki M., Murakami T., Sato J., Kobayashi H., et al. Branched-chain amino acid catabolism in exercise and liver disease. J Nutr 2006, 136:250S-253S.
56. Sharifi Y., Maria J., Noiret L., Habtesion A., Davies N., Jalan R. Administration of branched chain amino acids to hyperammonemic cirrhotic animals is associated with worsening of hyperammonemia and increase in brain oedema. Gut 2010, 59:A34.
57. Rudman D., Galambos J.T., Smith R.B., Salam A.A., Warren W.D. Comparison of the effect of various amino acids upon the blood ammonia concentration of patients with liver disease. Am J Clin Nutr 1973, 26:916-925.
58. Romero-Gómez M., Ramos-Guerrero R., Grande L., de Terán L.C., Corpas R., Camacho I., et al. Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy. J Hepatol 2004, 41:49-54.
59. Gelfand R.A., Glickman M.G., Jacob R., Sherwin R.S., DeFronzo R.A. Removal of infused amino acids by splanchnic and leg tissues in humans. Am J Physiol 1986, 250:E407-E413.
60. Manchester K.L. Oxidation of amino acids by isolated rat diaphragm and the influence of insulin. Biochim Biophys Acta 1965, 100:295-298.
61. Holecek M. Branched-chain amino acid oxidation in skeletal muscle-physiological and clinical importance of its modulation by reactant availability. Curr Nutr Food Sci 2011, 7:50-56.
62. Holecek M. Leucine metabolism in fasted and TNF treated rats. Clin Nutr 1996, 15:91-93.
63. Holecek M., Sprongl L., Skopec F., Andrys C., Pecka M. Leucine metabolism in TNF-α- and endotoxin-treated rats: contribution of hepatic tissue. Am J Physiol 1997, 273:E1052-E1058.
64. Lang C.H., Frost R.A. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle. J Cell Physiol 2005, 203:144-155.
65. Record C.O., Buxton B., Chase R.A., Curzon G., Murray-Lyon I.M., Williams R. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 1976, 6:387-394.
66. Rosen H.M., Yoshimura N., Hodgman J.M., Fischer J.E. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 1977, 72:483-487.
67. Holecek M., Skalska H., Mraz J. Plasma amino acid levels after carbon tetrachloride induced acute liver damage. A dose-response and time-response study in rats. Amino Acids 1999, 16:1-11.
68. van Berlo C.L., van de Bogaard A.E., van der Heijden M.A., van Eijk H.M., Janssen M.A., Bost M.C., et al. Is increased ammonia liberation after bleeding in the digestive tract the consequence of complete absence of isoleucine in hemoglobin? A study in pigs. Hepatology 1989, 10:315-323.
69. Olde Damink S.W., Jalan R., Deutz N.E., Dejong C.H., Redhead D.N., Hynd P., et al. Isoleucine infusion during "simulated" upper gastrointestinal bleeding improves liver and muscle protein synthesis in cirrhotic patients. Hepatology 2007, 45:560-568.
70. Yao K., Yin Y., Li X., Xi P., Wang J., Lei J., et al. Alpha-ketoglutarate inhibits glutamine degradation and enhances protein synthesis in intestinal porcine epithelial cells. Amino Acids 2012, 42:2491-2500.
71. Batshaw M.L., Walser M., Brusilow S.W. Plasma alpha-ketoglutarate in urea cycle enzymopathies and its role as a harbinger of hyperammonemic coma. Pediatr Res 1980, 14:1316-1319.
72. Chainuvati T., Plengvanit U., Viranuvatti V. Ornicetil on encephalopathy. Effect of ornicetil (ornithine alpha-ketoglutarate) on encephalopathy in patients with acute and chronic liver disease. Acta Hepatogastroenterol (Stuttg) 1977, 24:434-439.
73. Enns G.M., Berry S.A., Berry G.T., Rhead W.J., Brusilow S.W., Hamosh A. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 2007, 356:2282-2292.
74. Dam G., Ott P., Aagaard N.K., Vilstrup H. Branched-chain amino acids and muscle ammonia detoxification in cirrhosis. Metab Brain Dis 2013, [Epub ahead of print].